Arabidopsis thaliana (Arabidopsis) treated with the four stereoisomers of Brz220 (2RS, 4RS-1-[4-propyl-2-(4-trifluoromethylphenyl)-1, 3-dioxane-2-ylmethyl]-1H-1, 2, 4-triazole) showed a dwarf phenotype like brassinosteroid (BR) biosynthesis mutants that were rescued by treatment of BRs. The target sites of each Brz220 stereoisomer were investigated by treatment of Arabidopsis with BRs in the dark. The results suggest that the stereoisomers block the 22-hydroxylation step in BR biosynthesis. This step is catalyzed by DWF4, an Arabidopsis cytochrome P450 identified as a steroid 22-hydroxylase. The enzyme was expressed in E. coli, and the binding affinity of the stereoisomers to recombinant DWF4 was analyzed. The results indicate that in these stereoisomers there exists a positive correlation between binding affinity to DWF4 and inhibition of Arabidopsis hypocotyl growth. In this context, we concluded that DWF4 is the target site of Brz220 in Arabidopsis.
Arabidopsis thaliana (Arabidopsis) treated with the four stereoisomers of Brz220 (2RS, 4RS-1-[4-propyl-2-(4-trifluoromethylphenyl)-1, 3-dioxane-2-ylmethyl]-1H-1, 2, 4-triazole) showed a dwarf phenotype like brassinosteroid (BR) biosynthesis mutants that were rescued by treatment of BRs. The target sites of each Brz220 stereoisomer were investigated by treatment of Arabidopsis with BRs in the dark. The results suggest that the stereoisomers block the 22-hydroxylation step in BR biosynthesis. This step is catalyzed by DWF4, an Arabidopsis cytochrome P450 identified as a steroid 22-hydroxylase. The enzyme was expressed in E. coli, and the binding affinity of the stereoisomers to recombinant DWF4 was analyzed. The results indicate that in these stereoisomers there exists a positive correlation between binding affinity to DWF4 and inhibition of Arabidopsis hypocotyl growth. In this context, we concluded that DWF4 is the target site of Brz220 in Arabidopsis.
Key words: brassinosteroid; P450 inhibitor; azole A large number of synthetic azole compounds have been developed for medicinal and agricultural purposes. These include chemicals, such as anticancer agents, fungicides, and plant growth regulators (PGR). 1, 2) The major targets of some of these compounds are cytochrome P450s, which belong to the superfamily of oxidative catalysts involved in the biosynthesis and metabolism of biomolecules, such as steroids. Based on spectroscopic and X-ray crystallographic studies of P450 inhibitors, the azole moiety of the inhibitors is believed to act as a ligand that binds to the iron atom of the haem prosthetic group of the P450 enzyme, forming a coordination complex. Besides the azole moiety, the chemical structure of these inhibitors is thought to be an important factor in selectivity for different cytochrome P450s. This special type of binding is reflected in changes in the Soret absorption band. 3) In the absence of ligands, most P450s are in the low-spin state, with their Soret absorption peaks at around 417-419 nm. The addition of nitrogen-donors such as azole compounds shifts the Soret absorption peaks of P450 from 417-419 nm to 417-426 nm. 4) These are often referred to as Type II spectra. The shapes of the ligand-induced difference spectra of P450s depend on the ligand and its concentration. The spectral dissociation constant (K d ) was calculated from a double reciprocal plot of the observed spectral absorbance difference versus its ligand concentration. 5) Most azole compounds known as PGRs target cytochrome P450 in the gibberellin biosynthesis pathway.
2) On the other hand, some azole compounds affect the biosynthesis of brassinosteroids (BRs) in plants and induce dwarfism in azole-treated plants. 5) BRs are a group of plant steroid hormones that regulate numerous functions, such as plant growth and development, including stem elongation, leaf bending, tracheary element differentiation, and photomorphogenesis. These functions can be analyzed using BR biosynthesis y To whom correspondence should be addressed. Fax: +81-3-5841-8025; E-mail: asami@pgr1.ch.a.u-tokyo.ac.jp Abbreviations: PGR, plant growth regulators; BRs, brassinosteroids; CT, cathasterone; TE, teasterone; TY, typhasterol; CS, castasterone; BL, brassinolide mutants and/or inhibitors. 6, 7) Many oxidation steps of BR biosynthesis are thought to be catalyzed by P450s at C-2, C-3, C-6, C-22, C-23, and C-26 of the BRs (Fig. 1) . 8, 9) Several P450 genes in BR biosynthesis are regulated by brassinolide (BL), the most active BR, indicating that BL exerts a negative feedback effect on the expression of several P450 genes. [10] [11] [12] These P450s include the enzymes CYP90B/724B and CYP90C/90D, which catalyze C-22 monooxygenation and C-23 monooxygenation on the steroid side chain respectively. AtBR6ox catalyzes C-6 oxidation at the steroid Bring. 10) These steps are the key regulatory steps in BR biosynthesis, and the P450s can be the target candidate of a novel BR biosynthesis inhibitor. For these reasons, the inhibitory potency of known P450 inhibitors against BR biosynthesis was measured. Studies of chemical structure-activity relationships have revealed a novel group of potential BR biosynthesis inhibitor, Brz220. 13) Thus far, this compound is the most potent inhibitor of BR biosynthesis reported in vivo. Brz220 has two asymmetric carbon atoms (C-2 and C-4), and hence the structure can exist in four optically active forms (Fig. 2) . The biological activity of these compounds depends on their stereoisomeric forms, 14) suggesting a difference in their target sites or in their binding affinities to the same target site. First, to investigate the target site of the Brz220 stereoisomers, we determined whether they would induce dwarfism in Arabidopsis, and whether this phenotype would be rescued by BL or its precursors (CT, TE, TY, CS, and BL). On the basis of the result obtained in the above experiment, we focussed on CYP90B(DWF4) in Arabidopsis as the target site of Brz220. To determine whether DWF4 is the target site of Brz220, we analyzed the binding affinity of each Brz220 stereoisomer to DWF4 expressed in E. coli. In this report, we provide evidence that the Brz220 stereoisomers induced a BR deficiency phenotype by binding to DWF4.
Materials and Methods
Chemicals. BL and its precursors were purchased and synthesized as described previously.
5) The four Brz220 stereoisomers used in this study were synthesized and purified as reported previously.
14) The Murashige and Skoog salt and vitamin mixture was purchased from Gibco-BRL (Grand Island, NY).
Plant materials and growth conditions. Arabidopsis seeds (ecotype Columbia) were purchased from Lehle Seeds (Round Rock, TX). The seeds were cold-treated at 4 C for 3 d, then surface-sterilized in a 1% NaOCl solution for 10 min and washed 5 times with sterile distilled water. The seeds were sown on 0.8% agarsolidified medium containing half-strength Murashige and Skoog salts and 1.5% sucrose (w/v) on plastic plates with or without the chemicals. The test chemicals were dissolved and diluted with dimethyl sulfoxide (DMSO). The plates were sealed with Micropore surgical tape (3M Health Care, Broken, Germany) for the test. The Arabidopsis plants were grown in darkness in a growth chamber (22 C) for 5 d.
Expression of recombinant DWF4 protein in E. coli. DWF4 from Arabidopsis thaliana was expressed in E. coli DH5 cells as described previously.
15)
Binding assays of the stereoisomers of Brz220 to recombinant DWF4 proteins. Binding spectra with recombinant DWF4 were determined by differential spectroscopy using a Shimadzu UV-3100 spectrophotometer according to the method described previously.
5)
The concentrations of the azole compound ranged from 0.1 to 30 mM.
Computational method. The initial structures of Brz220 stereoisomers were generated and minimized using MM3 built into CAChe 3.11.
16) A conformational search was carried out focussing on dioxolane ring conformation and some dihedral angles of the initial structures. The lowest energy conformers were fully optimized by density functional theory, using the Becke three parameter hybrid functional (B3LYP) method and the 6-31G(d) basis set in Gaussian 03.
17)

Results and Discussion
Brassinolide and its precursors rescue Brz220-treated plants
Since the characterization of Arabidopsis BRs biosynthesis mutants established the BR biosynthetic pathway, these mutants have been used as materials in biological experiments. The phenotype of BR biosynthetic mutants and BR biosynthesis inhibitor-treated plants can revert to that of the wild type with exogenous application of bioactive BRs. 18 ) Hence a feeding experiment was done to determine the BR biosynthesis steps affected by the four Brz220 stereoisomers. Although some of the BR biosynthesis intermediates used in this experiment are not on the main BR biosynthesis pathway recently reported by Ohnishi et al., 9) the experiment still provided useful information about the target site of BR biosynthesis inhibitors. Each Brz220 stereoisomer was applied at a concentration that produced 50% inhibition of Arabidopsis hypocotyl growth as compared to the control, untreated etiolated Arabidopsis seedlings ( Table 1) . As shown in Fig. 3, 1 mM each of CT, teasterone (TE), and typhasterol (TY); 100 nM of castasterone (CS); and 10 nM of BL had no effect on untreated seedlings. On the other hand, Arabidopsis treated with each Brz220 stereoisomer in turn showed a rescue response when treated with BL and its precursors. In the feeding experiment, Arabidopsis treated with each Brz220 stereoisomer in turn did not completely revert the inhibition of hypocotyl growth due to BL and its precursors, maybe because of the slow uptake and transport of BRs within Arabidopsis.
5) The experiments indicated that each Brz220 stereoisomer acts at the reaction step upstream of the conversion step from CT to TE in BR biosynthesis. Eventually, there remained two cytochrome P450s in Arabidopsis, CYP51 and CYP90B, as possible target sites of Brz220 in the BR biosynthesis pathway, but the dwarf phenotype of the transgenic Arabidopsis defect in the function of CYP51 was not rescued by BR treatment, 19) perhaps due to a deficiency of sitosterol, stigmasterol, and campesterol, which are essential components of membrane and/or the accumulation of obtusifoliol and its derivatives which might show unknown plant growth regulatory activity. 20) On the basis of this result, we focussed on CYP90B (DWF4) as the target site of Brz220. Next, in order to determine whether each Brz220 stereoisomer would affect the function of DWF4, we investigated the affinity of each stereoisomer to recombinant DWF4 proteins.
Binding assay of the four stereoisomers of Brz220 to DWF4 UV-visible absorption spectroscopy provides a simple and accurate method to determine the binding of inhibitors to P450s. 1) In the case of DWF4 expressed in E. coli, it was found that the addition of steroid ligands shifted the Soret absorption peaks of P450 from 416 nm to 383 nm.
15) The addition of each Brz220 stereoisomer to the DWF4 protein induced a type II absorbance shift of the haem soret band from 414 nm to 420 nm (Fig. 4) . Based on an empirical rule as to the spectral properties of P450s, the spectral changes indicated that the nitrogen donor from the triazol of Brz220 coordinated to the haem iron of DWF4, and that each Brz220 stereoisomer in turn interacted with DWF4.
K d was determined by titrating the observed spectral absorbance difference (ÁA, 432-412) versus the concentration of their Brz220 stereoisomers ( Table 1 ). The potency of the binding affinity of DWF4 was as follows: Brz22012 (2S, 4R) > Brz22022 (2S, 4S) > Brz22011 (2R, 4S) > Brz22021 (2R, 4R). These results indicate that the (S) configuration at C-2 produces the most binding affinity and that this is enhanced by the (R) configuration at C-4, demonstrating stereo selectivity. The K d of Brz22012 and Brz22022 was lower than that of brassinazole (1.0 mM), the most potent inhibitor of DWF4 known at present (Table 1) . 5) To determine the correlation of binding affinity and inhibition of Arabidopsis hypocotyl growth, we compared the K d values with the I 50 values (Table 1) . When the K d values were plotted against the I 50 values, we obtained a high correlation coefficient (r ¼ 0:83). These data indicate that the Brz220 stereoisomers induce a BR-deficient phenotype by binding to DWF4.
The difference in the absolute configuration at C-2 and C-4 of Brz220 greatly affects biological activity. To determine the relationships between the steric structure and the inhibitory activity of the four isomers, the lowest energy conformer of each Brz220 stereoisomer was calculated. This is shown in Fig. 5 . When the four isomers are superimposed so that the triazole rings, the key component of inhibitor binding to the haem iron center in the active site of cytochrome P450, should overlap, they were classified into two groups on the basis of the spatial arrangement of the p-trifluoromethylphenyl group and thte dioxolane ring including the n-propyl side chain, as biologically potent Brz22012 and Brz22022 (right group in Fig. 5 ) and biologically less potent Brz22011 and Brz22021 (left group in Fig. 5 ). Each p-trifluoromethylphenyl group takes the same direction in the four isomers, but the n-propyl groups in Brz22012 and Brz22022 extend to the right and the npropyl groups in Brz22011 and Brz22021 extend to the left in Fig. 5 . This difference in the orientation of the npropyl groups may reflect differences both in binding affinity and in biological activity. The structure of Brz22012 and Brz22022 might be more suitable for fitting to the substrate-binding pocket in DWF4, and thus both chemicals showed more potent inhibitory activity than Brz22011 or Brz22021. Since Brz22011 and Brz22021 still possessed distinct inhibitory activity and binding affinity to DWF4, this difference in the orientation of the n-propyl group must not be the critical factor for Brz220 to bind to DWF4. In the stick models, carbons, hydrogens, and oxygens are colored gray, white, and red respectively. In the overlay structures, the isomers are depicted in the following colors: Brz22011, purple; Brz22012, yellow; Brz22021, cyan; Brz22022, red.
In conclusion, the binding affinity of the four Brz220 stereosiomers to recombinant DWF4 coincided with both binding affinity to DWF4 proteins and Arabidopsis growth inhibitory activity, suggesting a stereo-selective interaction of Brz220. In this context, DWF4 is the major site of Brz220 action. This study is the first attempt to correlate the binding affinity of the stereoisomers with their biological activity. These compounds are the most potent in vitro and in vivo inhibitors of BR biosynthesis identified thus far.
